FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

422157006: Anidulafungin (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2006. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2615100010 Anidulafungin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2617742018 Anidulafungin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
52391000195117 anidulafungina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
861251000172110 anidulafungine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
66731000195113 Anidulafungin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Anidulafungin (substance) Is a Echinocandin (substance) true Inferred relationship Some
Anidulafungin (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antifungal true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing anidulafungin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Anidulafungin (substance) Inferred relationship Some 1
Anidulafungin 50 mg powder for solution for injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anidulafungin (substance) Inferred relationship Some
Anidulafungin 100mg powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Anidulafungin (substance) Inferred relationship Some
Product containing only anidulafungin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Anidulafungin (substance) Inferred relationship Some 1
Anidulafungin 50 mg powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Anidulafungin (substance) Inferred relationship Some 1
Anidulafungin 50 mg powder for solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Anidulafungin (substance) Inferred relationship Some 1
Anidulafungin only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Anidulafungin (substance) Inferred relationship Some 1
Product containing anidulafungin in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Anidulafungin (substance) Inferred relationship Some 1
Product containing precisely anidulafungin 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Anidulafungin (substance) Inferred relationship Some 1
Product containing precisely anidulafungin 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Anidulafungin (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start